Literature DB >> 3030959

Timolol induces HSV-1 ocular shedding in the latently infected rabbit.

J M Hill, Y Shimomura, J B Dudley, E Berman, Y Haruta, B S Kwon, L J Maguire.   

Abstract

Timolol iontophoresis into the eye can induce herpes simplex virus type 1 (HSV-1) shedding in rabbits latently infected with HSV-1 strain McKrae. Anodal iontophoresis of 0.01% timolol was done at 0.8 mAmp for 8 min once a day for 3 consecutive days. Viral shedding was determined by the presence of HSV-1 in the preocular tear film obtained by eye swabs. In two experiments, iontophoresis of 0.01% timolol resulted in all eyes (18/18) shedding HSV-1 for an average duration of 4.3 days. When 5.0% timolol was applied topically to rabbit eyes supersensitized by iontophoresis of 6-hydroxydopamine (6-HD), all eyes (10/10) shed virus for an average duration of 2.9 days. All eyes (12/12) receiving iontophoresis of 6-HD, pre- and posttreatment with topical application of 5.0% timolol, and posttreatment with topical application of 1.0% epinephrine shed virus for an average duration of 3.6 days. Eyes treated with topical application of 5.0% timolol alone showed no difference in HSV-1 ocular shedding, compared with untreated eyes. We concluded that both iontophoresis of 0.01% timolol and topical application of 5.0% timolol to adrenergically supersensitized eyes induced HSV-1 shedding reliably and with a high frequency, and that topically applied timolol does not block the HSV-1 ocular shedding induced by epinephrine in adrenergically supersensitized eyes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030959

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

Review 1.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

2.  Impact of the use of anti-glaucoma medications on the risk of herpetic keratitis recurrence.

Authors:  Bonnie He; Hamid Tavakoli; Mahyar Etminan; Shayan Shokoohi; Alfonso Iovieno; Sonia N Yeung
Journal:  Int Ophthalmol       Date:  2022-10-12       Impact factor: 2.029

3.  HSV-1 latent rabbits shed viral DNA into their saliva.

Authors:  James M Hill; Nicole M Nolan; Harris E McFerrin; Christian Clement; Timothy P Foster; William P Halford; Konstantin G Kousoulas; Walter J Lukiw; Hilary W Thompson; Ethan M Stern; Partha S Bhattacharjee
Journal:  Virol J       Date:  2012-09-28       Impact factor: 4.099

4.  Herpetic uveitis caused by herpes simplex virus after cataract surgery in a patient without prior viral keratitis or uveitis: a case report.

Authors:  Feng Hu; Wenxue Guan; Yongpeng Zhang; Xiaoyan Peng
Journal:  BMC Ophthalmol       Date:  2022-03-05       Impact factor: 2.209

Review 5.  Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases.

Authors:  Jody M Webre; James M Hill; Nicole M Nolan; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Victor Hsia; Donna M Neumann; Timothy P Foster; Walter J Lukiw; Hilary W Thompson
Journal:  J Biomed Biotechnol       Date:  2012-10-02

6.  Microarray analysis of host gene expression for comparison between naïve and HSV-1 latent rabbit trigeminal ganglia.

Authors:  Christian Clement; Michael P Popp; David C Bloom; Gregory Schultz; Li Liu; Donna M Neumann; Partha S Bhattacharjee; James M Hill
Journal:  Mol Vis       Date:  2008-07-03       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.